The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6) ("Hydreight" or the "Company"), a North American, fully integrated, mobile clinical network ...

Plainsboro, New Jersey Monday, May 5, 2025, 14:00 Hrs [IST] ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...